hrp0084p2-351 | Fat | ESPE2015

Domino Liver Transplantation for the Pre-Emptive Therapy of Compound Heterozygous Familial Hypercholesterolemia: A Case of 2-Year-Old Girl

Tanaka Hiroyuki , Sugawara Daisuke , Tanaka Yasuko , Yoshida Tomoko , Nakao Kanako , Uchida Noboru , Yamamoto Akiko , Fukuda Akinari , Kasahara Mureo , Horikawa Reiko

Background: Patients with homozygous and compound heterozygous familial hypercholesterolemia (FH) have markedly elevated plasma LDL cholesterol (LDL-C) from birth. If untreated, patients develop cardiovascular atherosclerosis resulting in death before the second decade of life. Medication and apheresis are only partially effective in reducing LDL-C levels, and do not significantly improve the prognosis. Liver transplantation (LT) can nearly normalize the cholesterol metabolism...

hrp0084p3-681 | Bone | ESPE2015

A Case of Vitamin D Deficient Rickets Showing Resistance to the Treatment of Active Vitamin D: Severe Calcium Deficiency Cause Vitamin D Resistance

Tanaka Hiroyuki , Hasegawa Kosei , Takatsuka Moe , Okahara Chika , Noguchi Yoshie , Takata Tsutomu , Ogura Kazuo

Case presentation: A 2-year-boy was referred tour hospital for the rickets. He was the first son between non-consanguineous parents and fed with breast milk. But after weaning, he was avoided from taking egg, dairy products including cow’s milk. He was also suffered from developmental delay and had strong food preference. He could take only two kinds of foods, steamed rice and soy bean product, tofu. X-ray findings showed typical rachitic change on long bone metaphysis. L...

hrp0084p3-1022 | Growth | ESPE2015

Postnatal Growth and Biochemical Markers of Late Preterm Infants: Prospective Birth Cohort

Yoshida Tomoko , Takahashi Chie , Uchida Noboru , Nakao Kanako , Sugawara Daisuke , Tanaka Yasuko , Tanaka Hiroyuki , Chiba Yuta , Terada Yumiko , Mizutani Kazuko , Naiki Yasuhiro , Horikawa Reiko

Background: Late preterm birth (defined as infants born between 34 and 36 weeks of gestational age) is increasing worldwide. Their postnatal growth has not been fully investigated.Objective and hypotheses: To identify the characteristics of postnatal growth and biochemical markers in late preterm infants.Method: Among 2014 children in the birth cohort study conducted from 2010, 51 children were born late preterm with birth weight a...

hrp0095fc2.4 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

Patient-reported outcomes from a randomized open-label phase 3 trial comparing burosumab vs conventional therapy in children with X-linked hypophosphatemia: results from the 24-week treatment extension period

Padidela Raja , Whyte Michael P , Glorieux Francis H , Munns Craig F , Ward Leanne M , Nilsson Ola , Portale Anthony A , Simmons Jill H , Namba Noriyuki , Cheong Hae Il , Pitukcheewanont Pisit , Sochett Etienne , Högler Wolfgang , Muroya Koji , Tanaka Hiroyuki , Gottesman Gary S , Biggin Andrew , Perwad Farzana , Williams Angela , Nixon Annabel , Sun Wei , Chen Angel , Skrinar Alison , Imel Erik A

In a randomized open-label phase 3 trial in 62 children (1–12 years) with X-linked hypophosphatemia (XLH) (NCT 02915705), switching from conventional therapy (oral phosphate plus active vitamin D) to burosumab, a monoclonal antibody targeting fibroblast growth factor 23, significantly improved serum phosphate concentration, rickets, lower-extremity deformities, growth, mobility, and patient-reported outcomes (PROs) at 64 weeks. Children in Europe, USA, Canada, and Australia wh...

hrp0086p1-p911 | Thyroid P1 | ESPE2016

Hyperthyroidism after Bone Marrow Transplantation: A Report of Two Cases

Ishiguro Hiroyuki , Hyodo Hiromi , Kato Shunichi

Background: The thyroid dysfunction is one of the frequently seen complications after bone marrow transplantation (BMT). Although hypothyroidism is the most common thyroid disease after BMT, hyperthyroidism is a rare condition. Herein, we report a series of 2 patients who were euthyroid before BMT but developed hyperthyroidism after transplantation.Objective: Case reports and the frequency of hyperthyroidism after BMT in our institute. Case 1:</s...

hrp0092fc3.4 | Multi-system Endocrine Disorders | ESPE2019

Droplet Digital PCR is a Useful Method for Detection of Mosaic Mutations in Patients with McCune-Albright Syndrome

Watanabe Satoshi , Dateki Sumito , Moriuchi Hiroyuki , Yoshiura Koh-ichiro

Introduction: McCune-Albright syndrome (MAS) is caused by somatic mosaic mutations in the GNAS gene. Detection of the GNAS mutations is usually difficult because of the low frequency mosaicism. Droplet digital polymerase chain reaction (ddPCR) is a new technology that enables to measure absolute quantities of target nucleic acids in a sample by counting nucleic acid molecules encapsulated in discrete water-in-oil droplet partitions.<p cla...

hrp0089p2-p265 | Growth &amp; Syndromes P2 | ESPE2018

A Novel Heterozygous Missense Variant in the LZTR1 Gene as a Cause of Noonan Syndrome

Dateki Sumito , Watanabe Satoshi , Yoshiura Koh-ichiro , Moriuchi Hiroyuki

Background: Noonan syndrome (NS) is an autosomal dominant disorder characterized by a short stature, congenital heart defects, and characteristic facial features. Gain-of-function mutations of multiple genes in the Ras/mitogen activated protein kinase pathway have been identified in 70–80% of patients with NS. Recently, leucine-zipper-like transcription regulator 1 (LZTR1), which has not previously been associated with the pathway, was reported as a new causative...

hrp0089p2-p383 | Thyroid P2 | ESPE2018

A Successful Switch Experience from High-dose PTU to MMI on Day 4 of Graves’ Thyroid Storm in a 14-Year-Old Girl

Shinohara Hiroyuki , Iwabuchi Atsushi , Yamada Akiko , Kai Tomomi , Kamoda Tomohiro

Background: The standard pharmacological treatment strategy of thyroid storm according to 2016 Japan Society of Pediatric Endocrinology Guideline. Although thiamazole (MMI) is recommended be used as the first choice in Graves’ disease, the effect of propylthiouracil (PTU) to block the conversion from T4 to T3 in peripheral tissues encourages clinicians to use against thyroid storm in its very early phase, and switch to MMI later. Nevertheless, the optimal timing of the sw...

hrp0084p3-1173 | Thyroid | ESPE2015

Avoidable Thiamazole-Induced Omphalomesenteric Duct Remnants: 20-Year Retrospective Study in Our Hospital

Shinohara Hiroyuki , Komori Koji , Hirobe Seiichi , Hasegawa Yukihiro

Background: Although thiamazole (MMI) is the first-line treatment for non-pregnant women with Graves’ disease, the teratogenic effects of this drug have been confirmed. Surgical anomalies known as ‘major MMI-related anomalies’ include omphalomesenteric duct remnants. This is a common difficulty when attempting to clarify whether there is any association between infrequent surgical anomalies and MMI exposure using data derived from women with Graves’ disease...

hrp0086rfc12.1 | Neuroendocrinology | ESPE2016

Molecular Genetic Diagnosis of Idiopathic Hypogonadotropic Hypogonadism by Using Targeted Next-Generation Sequencing

Aoyama Kohei , Suzuki Atsushi , Tanaka Tatsushi , Mizuno Haruo , Saitoh Shinji

Background: Idiopathic hypogonadotropic hypogonadism (IHH) is a congenital heterogeneous disorder characterized by a deficiency of gonadotropin-releasing hormone. IHH can be categorised as IHH with anosmia/hyposmia (Kallmann syndrome: KS) or as normosmic (n)IHH. More than 25 genes have been identified in IHH. Nevertheless, patients with IHH are genetically diagnosed in only less than 50%.Objective: The objective of this study is to confirm the applicatio...